{
  "ticker": "JNJ",
  "target_date": "2025-11-05",
  "actual_date": "2025-11-05",
  "collected_at": "2025-12-08T12:29:39.603875",
  "price": {
    "open": 185.46,
    "high": 186.64,
    "low": 184.23,
    "close": 184.8264923095703,
    "volume": 5049400,
    "change_1d_pct": -0.46,
    "change_7d_pct": -2.26,
    "change_30d_pct": 5.27
  },
  "technicals": {
    "rsi_14": 32.55,
    "sma_20": 188.92,
    "sma_50": 182.7,
    "macd": 0.656,
    "macd_signal": 1.716,
    "macd_histogram": -1.06,
    "bb_upper": 193.8,
    "bb_lower": 184.04,
    "price_vs_sma20_pct": -2.17,
    "price_vs_sma50_pct": 1.16,
    "volume_ratio": 0.61
  },
  "fundamentals": {
    "market_cap": 487817707520,
    "pe_ratio": 19.543747,
    "forward_pe": 19.101246,
    "price_to_book": 6.145422,
    "price_to_sales": 5.2937927,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.57,
    "pct_from_52w_low": 43.92
  },
  "macro": {
    "spy": {
      "price": 677.58,
      "change_1d_pct": 0.35,
      "change_7d_pct": -1.38
    },
    "vix": {
      "level": 18.01,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.16
    },
    "dollar_index": {
      "level": 100.2
    },
    "gold": {
      "price": 3980.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here\u2019s Why.",
      "source": "Yahoo",
      "datetime": 1762371480,
      "summary": "Zimmer Biomet, the maker of knee and hip replacements, missed on quarterly sales estimates and lowered the top end of its outlook for full-year organic revenue growth.",
      "url": "https://finnhub.io/api/news?id=239f9b7ca0a734edae4973b6940b065fba19b3b7fa541a2dbada12db627a13d7"
    },
    {
      "headline": "Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It",
      "source": "Yahoo",
      "datetime": 1762351205,
      "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=7f00b388f77788dd51348da441406c308875bdaef2a84b828f37302fc6692124"
    },
    {
      "headline": "November's Dog Of The Dow Ideal \"Safer\" Buy: Verizon",
      "source": "SeekingAlpha",
      "datetime": 1762339775,
      "summary": "Verizon (VZ) stands out as the only Dow stock meeting the 'dogcatcher' ideal this month: annual dividends from $1K invested exceed its share price. Read the full analysis here.",
      "url": "https://finnhub.io/api/news?id=91830b4840aafb87613d9c0d6cef397c422f6a9d070fadfaadaf363eddad3c93"
    },
    {
      "headline": "Jim Cramer Just Couldn\u2019t Help Himself When Talking About Kimberly-Clark (KMB)\u2019s Kenvue Acquisition",
      "source": "Yahoo",
      "datetime": 1762339771,
      "summary": "We recently published 11 Latest Stocks Jim Cramer Talked About. Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks Jim Cramer recently discussed. Along with OpenAI\u2019s Amazon deal, Kimberly-Clark Corporation (NASDAQ:KMB) also made headlines after it announced that it would acquire household ",
      "url": "https://finnhub.io/api/news?id=255b82e0d568bb08ad7ba3c471dfb95d3787dc9409ecf3a14a463115eea1b2e7"
    },
    {
      "headline": "Tracking AMG's Yacktman Asset Management Portfolio - Q3 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1762295674,
      "summary": "Discover Yacktman Asset Management's Q3 2025 portfolio moves, key holdings, and strategy insights.",
      "url": "https://finnhub.io/api/news?id=467305fe3a0b54094e9177db03d8a88282e46b4bb97a7db017c7b02e4954ee6a"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    },
    {
      "form": "8-K",
      "date": "2025-10-14",
      "description": "jnj-20251014.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}